体现实践成果，引领未来方向:国际妇产科联盟2018年宫颈癌分期解读

Reflecting the Achievements of Practice and Leading the Future Direction:Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018

一直以来,国际妇产科联盟(International Federation of Gynecology and Obstetrics,FIGO)的宫颈癌分期都是临床分期。但随着诊断技术的发展、手术方式的进步以及对宫颈癌预后的了解加深,过去的FIGO分期已不能很好地推测宫颈癌预后及指导临床治疗选择。因此,FIGO在2009年宫颈癌分期的基础上,引入了近10年来宫颈癌诊治的新进展,形成了2018年宫颈癌分期。新的分期主要体现在肿瘤大小的分层更加细化,且纳入了淋巴结转移情况。本文对FIGO的2018年宫颈癌分期变化及其临床意义进行解读。

For years,the cervical cancer staging of the International Federation of Gynecology and Obstetrics(FIGO)are of clinical staging.However,with the development of diagnostic techniques,advances in surgical procedures,and a deeper understanding of the prognosis of cervical cancer,the old FIGO staging has not been able to well predict the prognosis of cervical cancer and to help the choice of treatment.Therefore,on the basis of the cervical cancer staging in 2009,FIGO introduced new progress in the diagnosis and treatment of cervical cancer in the past 10 years and formed the new staging of cervical cancer in 2018.The new staging system mainly reflects a more detailed stratification of the tumor size and the inclusion of lymph node metastasis.This article explains the changes in the cervical cancer staging of FIGO 2018 and its clinical significance.